According to the Center for Disease Control (CDC) approximately 1 in 150 school age children have Autism Spectrum Disorder (ASD).

Autism is more common than multiple sclerosis, cystic fibrosis or childhood cancer.

Autism is the third most common developmental disability following mental retardation and cerebral palsy.

Autism receives less than 5% of the research funding as compared to less common diseases.

Autism is a condition for which treatments are specifically excluded by most insurance companies.

Autism growth rate has risen to over 110% per year, compared to 17.5% for mental retardation, 12.6% for epilepsy, and 12.4% for cerebral palsy.

Autism does not have to be a permanent, irreversible condition for all children—many have recovered from Autism and a significant number are now indistinguishable from their peers.

Effective treatments are now available based on scientific and clinical research of ASD and include: medical interventions, vitamin and mineral supplementation, diet, and behavioral therapies.